Inside News

16 / 64

Research
16 Inside News
The investigators are extremely grateful
to the Radiation Oncology Research
Committee, the College and Ferring
Pharmaceuticals for this grant which
has made it possible for the study to be
undertaken.
The investigators are: N. Kumar
Gogna1, Catherine Bettington 3, Tanya
Holt1 , Brigid Hickey1, Margot Lehman2,
Adrienne See2 and Lee Tripcony3.
1) Radiation Oncology Mater Centre
(PAH) Brisbane, Qld. 2) Princess
Alexandra Hospital, Brisbane Qld. 3)
Royal Brisbane Hospital, Brisbane Qld.
References:
1. Otnes B, Harvei S, Fossa SD. The burden of
prostate cancer from diagnosis until death.
British Journal of Urology 1995;76:587-94.
2. Fossa SD, Dearnaley DP, Law M, Gad J,
Newling DW, Tveter K. Prognostic factors in
hormone-resistant progressing cancer of the
prostate. Annals of Oncology 1992;3:361-6.
3. Kamat AM, Huang SF, Bermejo CE, et al.
Total pelvic exenteration: effective palliation
of perinealpain in patients with locally
recurrent prostate cancer. Journal of Urology
2003;170:1868-71.
4. Hindson B, Turner S, Do V. Palliative radiation
therapy for localized prostate symptoms
in hormone refractory prostate cancer.
Australas Radiol 2007;51:584-8.
5. Furuya Y, Akakura K, Akimoto S, Ichikawa T,
Ito H. Radiotherapy for local progression in
patients with hormone-refractory prostate
cancer. International Journal of Urology
1999;6:187-91.
6. Hernes EH, Linja M, Fossa SD, et al.
Hormone-resistant prostate cancer with
symptomatic pelvic tumours: patient survival
and prognostic factors. BJU International
2000;86:240-7.
7. Fossa SD. Palliative pelvic radiotherapy in
patients with hormone-resistant prostatic
cancer. Progress in Clinical & Biological
Research 1987;243B:479-85.
8. Lankford SP, Pollack A, Zagars GK.
Radiotherapy for regionally localized
hormone refractory prostate cancer. Int J
Radiat Oncol Biol Phys 1995;33:907-12.
9. Gogna NK, Baxi S, Hickey B, Baumann K,
Burmeister E, Holt T. Split-course, high-
dose palliative pelvic radiotherapy for
locally progressive hormone-refractory
prostate cancer. Int J Radiat Oncol Biol Phys
2012;83:e205-11.
10. PP, Pilepich MV, Krall JM, et al. The effect of
overall treatment time on the outcome of
definitive radiotherapy for localized prostate
carcinoma: the Radiation Therapy Oncology
Group 75-06 and 77-06 experience. Int J
Radiat Oncol Biol Phys 1991;21:925-33.
11. Din OS, Thanvi N, Ferguson CJ, et al.
Palliative prostate radiotherapy for
symptomatic advanced prostate cancer.
Radiotherapy & Oncology 2009;93:192-6.
12. Wei JT, Dunn RL, Litwin MS, Sandler HM,
Sanda MG. Development and validation
of the expanded prostate cancer index
composite (EPIC) for comprehensive
assessment of health-related quality of
life in men with prostate cancer. Urology
2000;56:899-905.
Research Awards
Applications Closing
Please visit the College website for
guidelines and application forms
prizes/research-awards-a-grant
• Clinical Radiology Early Career
Researchers Prize
• Varian Medical Systems
Educational Grants
• Ferring Pharmaceuticals Grant
• Genito-Urinary Fellowship Grant
• Withers and Peters Grant
• Windeyer Fellowship
• Bourne and Langlands Prize
Guidelines and nomination forms can be
downloaded from the College website
prizes/research-awards-a-grant
Applications for the above research
awards close Friday 8 April 2016.
RANZCR Research Grants 2016 –
Clinical Radiology and Radiation
Oncology
The College’s research grants are to
support Fellows, Educational Affiliates
and student members of the College
engaged in research. Recipients
will be determined by the Research
Committees for clinical radiology and
radiation oncology.
Guidelines and application forms can be
downloaded from the College website:
prizes/research-awards-a-grant
Applications for RANZCR Research
Grants close Thursday 30 June 2016.
Further Information
If you need any further
information or have any questions,
please contact Manager, Research
Co-ordination at the College
on
or +61 2 9268 9732